NASDAQ$BRKR
Bruker Corp · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Bruker's Q4 2021 financial results were reported, showing revenue growth and EPS increase.
Bruker reported Q4 2021 revenues of $683.5 million, an 8.9% increase year-over-year, with organic revenue growth of 11.4%. GAAP EPS was $0.50, and non-GAAP EPS was $0.59, up $0.01 year-over-year. The company anticipates solid organic revenue and non-GAAP EPS growth in FY 2022.
- Q4 2021 revenues reached $683.5M, reflecting an 8.9% year-over-year increase.
- Organic revenue growth for Q4 2021 was 11.4% year-over-year.
- Q4 2021 GAAP EPS stood at $0.50, while non-GAAP EPS reached $0.59, a $0.01 increase year-over-year.
- Bruker anticipates robust organic revenue and non-GAAP EPS growth in FY 2022, driven by investments in Project Accelerate 2.0 initiatives.
Headline financials
Revenue & EPS history
Bruker · Revenue · Quarterly
$684M
Revenue by segment
Bruker · $57.8M total across 1 segment · Q4 2021
- BEST$57.8M+5.7%100.0%
Forward guidance
Bruker expects approximately 5% to 7% year-over-year revenue growth, including organic revenue growth of approximately 6% to 8%, M&A contribution of approximately 1%, and foreign currency translation headwind of approximately -2%. In FY 2022, Bruker expects non-GAAP operating margin expansion of 30 bps to 60 bps year-over-year, from 19.4% in FY 2021. Finally, Bruker expects FY 2022 non-GAAP EPS of $2.29 to $2.33, a 9% to 11% increase year-over-year.
Tailwinds
- Approximately 5% to 7% year-over-year revenue growth is expected.
- Organic revenue growth of approximately 6% to 8% is anticipated.
- M&A is expected to contribute approximately 1%.
- Non-GAAP operating margin expansion of 30 bps to 60 bps year-over-year is projected.
- FY 2022 non-GAAP EPS is expected to be $2.29 to $2.33, a 9% to 11% increase year-over-year.
Headwinds
- Foreign currency translation headwind of approximately -2% is expected.
- Supply chain and inflation challenges will likely persist through H1 2022.
- First-half operating margins are expected to be about 500-600 bps lower than second-half operating margins.
- R&D investments are planned to be approximately 10% of revenue during FY 2022.
- Unable to predict with reasonable certainty certain items that may affect such measures calculated and presented in accordance with GAAP without unreasonable effort.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
+0.8%
Avg return
Earnings day
+0.5%
Avg return
5 days after
+3.3%
Avg return
30 days after
54%
35 / 65 earnings
Positive
+14.1%
Q1 2019
Best reaction
-13.1%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +11.2% | +13.8% | +48.3% | |
| Q4 2025 | -11.6% | -10.2% | -20.5% | |
| Q3 2025 | +6.4% | +2.5% | +22.9% | |
| Q1 2025 | +3.4% | +2.1% | -2.9% | |
| Q4 2024 | -1.0% | -1.7% | -11.0% | |
| Q3 2024 | -0.6% | -2.7% | -1.5% | |
| Q2 2024 | -5.1% | -2.4% | +2.8% | |
| Q1 2024 | -11.4% | -5.9% | -17.1% | |
| Q4 2023 | +13.4% | +15.9% | +30.1% | |
| Q3 2023 | +3.2% | +2.2% | +15.9% | |
| Q2 2023 | -6.7% | -7.6% | -7.1% | |
| Q1 2023 | -2.1% | -4.9% | -11.0% | |
| Q4 2022 | +5.2% | +7.3% | +1.0% | |
| Q3 2022 | +9.5% | +8.7% | +9.6% | |
| Q2 2022 | -7.4% | -9.3% | -18.2% | |
| Q1 2022 | +1.2% | -4.0% | +5.3% | |
| Q4 2021 | -7.7% | -3.9% | -12.1% | |
| Q3 2021 | +1.7% | +1.7% | +0.9% | |
| Q2 2021 | -1.8% | +0.4% | +8.7% | |
| Q1 2021 | -0.5% | -0.0% | +1.4% | |
| Q4 2020 | +1.1% | +3.5% | -1.1% | |
| Q3 2020 | +3.4% | +9.2% | +21.6% | |
| Q2 2020 | +0.2% | -1.1% | -4.1% | |
| Q1 2020 | +6.2% | +4.3% | +16.9% | |
| Q4 2019 | -4.0% | -21.4% | -8.1% | |
| Q3 2019 | +12.4% | +6.8% | +14.9% | |
| Q2 2019 | -13.1% | -12.7% | -9.8% | |
| Q1 2019 | +14.1% | +11.3% | +9.6% | |
| Q4 2018 | +6.3% | +7.4% | +8.5% | |
| Q3 2018 | +6.6% | +6.9% | +5.8% | |
| Q2 2018 | +7.4% | +7.0% | +9.1% | |
| Q1 2018 | +2.0% | +2.9% | +3.4% | |
| Q4 2017 | -7.8% | -5.9% | -6.8% | |
| Q3 2017 | +4.5% | +2.8% | +9.2% | |
| Q2 2017 | -1.2% | -3.1% | +3.2% | |
| Q1 2017 | +3.8% | +4.7% | +12.1% | |
| Q4 2016 | -1.8% | -1.2% | -3.1% | |
| Q3 2016 | +3.6% | +8.9% | +10.1% | |
| Q2 2016 | -12.2% | -10.6% | -9.6% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | +9.5% | — | — | |
| Q3 2015 | +7.8% | — | — | |
| Q2 2015 | -5.4% | — | — | |
| Q1 2015 | +10.6% | — | — | |
| Q4 2014 | -2.1% | — | — | |
| Q3 2014 | -12.5% | — | — | |
| Q2 2014 | -9.4% | — | — | |
| Q1 2014 | -0.8% | — | — | |
| Q4 2013 | +2.0% | — | — | |
| Q3 2013 | -7.1% | — | — | |
| Q2 2013 | +11.1% | — | — | |
| Q1 2013 | -4.3% | — | — | |
| Q4 2012 | +8.3% | — | — | |
| Q3 2012 | +4.1% | — | — | |
| Q2 2012 | -1.6% | — | — | |
| Q1 2012 | +7.4% | — | — | |
| Q4 2011 | -0.9% | — | — | |
| Q4 2009 | -0.9% | — | — | |
| Q3 2010 | -4.0% | — | — | |
| Q3 2011 | -4.0% | — | — | |
| Q2 2010 | +4.0% | — | — | |
| Q2 2011 | +4.0% | — | — | |
| Q1 2010 | +1.9% | — | — | |
| Q4 2010 | +1.9% | — | — | |
| Q1 2011 | +1.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro